title: Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy.
authors: Johanna
authors: J
authors: Buchroithner
authors: Josef
authors: J
authors: Pichler
authors: Christine
authors: C
authors: Marosi
authors: Georg
authors: G
authors: Widhalm
authors: Marcel
authors: M
authors: Seiz-Rosenhagen
authors: Martha
authors: M
authors: Novosielski
authors: Stefan
authors: S
authors: Oberndorfer
authors: Reinhard
authors: R
authors: Ruckser
authors: Karl
authors: K
authors: Rössler
authors: Amedeo
authors: A
authors: Azizi
authors: Gord
authors: G
authors: von Campe
authors: Karin
authors: K
authors: Bordihn
authors: Thomas
authors: T
authors: Felzmann
mesh_terms: D001932:Brain Neoplasms / Q000628:therapy*; D003713:Dendritic Cells / Q000276:immunology*; D005909:Glioblastoma / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D042461:Vascular Endothelial Growth Factor A